{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:57:32Z","timestamp":1778569052027,"version":"3.51.4"},"reference-count":44,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.5551\/jat.63305","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T22:09:50Z","timestamp":1645826990000},"page":"1823-1834","source":"Crossref","is-referenced-by-count":10,"title":["Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction"],"prefix":"10.5551","volume":"29","author":[{"given":"Masahito","family":"Iioka","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"},{"name":"Department of Metabolism and Atherosclerosis, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Natsukawa","sequence":"additional","affiliation":[{"name":"Department of Emergency and Intensive care, Yodogawa Christian Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunbun","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Adipose Management, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujishima","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Sawano","sequence":"additional","affiliation":[{"name":"Senri Critical Care Medical Center, Osaka Saiseikai Senri Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res Commun, 2012; 425: 560-564","DOI":"10.1016\/j.bbrc.2012.08.024"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med, 2006; 3: 35-42","DOI":"10.1038\/ncpcardio0380"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb, 2011; 18: 629-639","DOI":"10.5551\/jat.7922"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Maeda N, Funahashi T, Matsuzawa Y, Shimomura I. Adiponectin, a unique adipocyte-derived factor beyond hormones. Atherosclerosis, 2020; 292: 1-9","DOI":"10.1016\/j.atherosclerosis.2019.10.021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol, 2000; 20: 1595-1599","DOI":"10.1161\/01.ATV.20.6.1595"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 2002; 360: 57-58","DOI":"10.1016\/S0140-6736(02)09335-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol, 2003; 23: 85-89","DOI":"10.1161\/01.ATV.0000048856.22331.50"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004; 291: 1730-1737","DOI":"10.1001\/jama.291.14.1730"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ohashi T, Shibata R, Morimoto T, Kanashiro M, Ishii H, Ichimiya S, Hiro T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura T, Daida H, Murohara T, Matsuzaki M. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. Atherosclerosis, 2010; 212: 237-242","DOI":"10.1016\/j.atherosclerosis.2010.05.005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Juonala M, Saarikoski LA, Viikari JS, Oikonen M, Lehtim\u00e4ki T, Lyytik\u00e4inen LP, Huupponen R, Magnussen CG, Koskinen J, Laitinen T, Taittonen L, K\u00e4h\u00d6nen M, Kivim\u00e4ki M, Raitakari OT. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study. Atherosclerosis, 2011; 217: 234-239","DOI":"10.1016\/j.atherosclerosis.2011.03.016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis, 2011; 217: 543-548","DOI":"10.1016\/j.atherosclerosis.2011.05.035"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Imanishi Y, Miyagawa S, Maeda N, Fukushima S, Kitagawa-Sakakida S, Daimon T, Hirata A, Shimizu T, Okano T, Shimomura I, Sawa Y. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure. Circulation, 2011; 124: S10-S17","DOI":"10.1161\/CIRCULATIONAHA.110.009993"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Natsukawa T, Maeda N, Fukuda S, Yamaoka M, Fujishima Y, Nagao H, Sato F, Nishizawa H, Sawano H, Hayashi Y, Funahashi T, Kai T, Shimomura I. Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction. J Atheroscler Thromb, 2017; 24: 793-803","DOI":"10.5551\/jat.38232"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Shimabukuro M. Adiponectin and T-Cadherin: a Tree for Biomarkers in ST-Elevation or Non-ST-Elevation Myocardial Infarction. J Atheroscler Thromb, 2017; 24: 788-790","DOI":"10.5551\/jat.ED073"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003; 423: 762-769","DOI":"10.1038\/nature01705"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S, Walsh K. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest, 2007; 117: 375-386","DOI":"10.1172\/JCI29709"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes, 2007; 56: 2174-2177","DOI":"10.2337\/db07-0185"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb, 2010; 17: 1201-1211","DOI":"10.5551\/jat.6106"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Baessler A, Schlossbauer S, Stark K, Strack C, Riegger G, Schunkert H, Hengstenberg C, Fischer M. Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men. J Atheroscler Thromb, 2011; 18: 616-627","DOI":"10.5551\/jat.8359"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30\/adiponectin. Proc Natl Acad Sci U S A, 2004; 101: 10308-10313","DOI":"10.1073\/pnas.0403382101"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nishizawa H, Funahashi T, Takagi J, Maeda N, Shimomura I. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2. J Biol Chem, 2017; 292: 7840-7849","DOI":"10.1074\/jbc.M117.780734"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Matsuda K, Fujishima Y, Maeda N, Mori T, Hirata A, Sekimoto R, Tsushima Y, Masuda S, Yamaoka M, Inoue K, Nishizawa H, Kita S, Ranscht B, Funahashi T, Shimomura I. Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. Endocrinology, 2015; 156: 934-946","DOI":"10.1210\/en.2014-1618"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ranscht B, Dours-Zimmermann MT. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron, 1991; 7: 391-402","DOI":"10.1016\/0896-6273(91)90291-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest, 2010; 120: 4342-4352","DOI":"10.1172\/JCI43464"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Parker-Duffen JL, Nakamura K, Silver M, Kikuchi R, Tigges U, Yoshida S, Denzel MS, Ranscht B, Walsh K. T-cadherin is essential for adiponectin-mediated revascularization. J Biol Chem, 2013; 288: 24886-24897","DOI":"10.1074\/jbc.M113.454835"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Fujishima Y, Maeda N, Matsuda K, Masuda S, Mori T, Fukuda S, Sekimoto R, Yamaoka M, Obata Y, Kita S, Nishizawa H, Funahashi T, Ranscht B, Shimomura I. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis. FASEB J, 2017; 31: 1571-1583","DOI":"10.1096\/fj.201601064R"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Tanaka Y, Kita S, Nishizawa H, Fukuda S, Fujishima Y, Obata Y, Nagao H, Masuda S, Nakamura Y, Shimizu Y, Mineo R, Natsukawa T, Funahashi T, Ranscht B, Fukada SI, Maeda N, Shimomura I. Adiponectin promotes muscle regeneration through binding to T-cadherin. Sci Rep, 2019; 9: 16","DOI":"10.1038\/s41598-018-37115-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tsugawa-Shimizu Y, Fujishima Y, Kita S, Minami S, Sakaue TA, Nakamura Y, Okita T, Kawachi Y, Fukada S, Namba-Hamano T, Takabatake Y, Isaka Y, Nishizawa H, Ranscht B, Maeda N, Shimomura I. Increased vascular permeability and severe renal tubular damage after ischemia-reperfusion injury in mice lacking adiponectin or T-cadherin. Am J Physiol Endocrinol Metab, 2021; 320: E179-E190","DOI":"10.1152\/ajpendo.00393.2020"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, Ting CT, Sheu SH, Tsai WC, Chen JH, Lin SJ, Chen YT, Pan WH. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes, 2011; 60: 2417-2423","DOI":"10.2337\/db10-1321"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, Okayama A, Morisaki T. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat, 2012; 33: 402-410","DOI":"10.1002\/humu.21652"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Gao H, Kim YM, Chen P, Igase M, Kawamoto R, Kim MK, Kohara K, Lee J, Miki T, Ong RT, Onuma H, Osawa H, Sim X, Teo YY, Tabara Y, Tai ES, van Dam RM. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes, 2013; 62: 4277-4283","DOI":"10.2337\/db13-0129"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kitamoto A, Kitamoto T, Nakamura T, Matsuo T, Nakata Y, Hyogo H, Ochi H, Kamohara S, Miyatake N, Kotani K, Mineo I, Wada J, Ogawa Y, Yoneda M, Nakajima A, Funahashi T, Miyazaki S, Tokunaga K, Masuzaki H, Ueno T, Chayama K, Hamaguchi K, Yamada K, Hanafusa T, Oikawa S, Sakata T, Tanaka K, Matsuzawa Y, Hotta K. CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass. J Atheroscler Thromb, 2016; 23: 309-319","DOI":"10.5551\/jat.31567"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Obata Y, Kita S, Koyama Y, Fukuda S, Takeda H, Takahashi M, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nakamura Y, Nishizawa H, Funahashi T, Ranscht B, Izumi Y, Bamba T, Fukusaki E, Hanayama R, Shimada S, Maeda N, Shimomura I. Adiponectin\/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. JCI Insight, 2018; 3: e99680","DOI":"10.1172\/jci.insight.99680"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Nakamura Y, Kita S, Tanaka Y, Fukuda S, Obata Y, Okita T, Nishida H, Takahashi Y, Kawachi Y, Tsugawa-Shimizu Y, Fujishima Y, Nishizawa H, Takakura Y, Miyagawa S, Sawa Y, Maeda N, Shimomura I. Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice. Mol Ther, 2020; 28: 2203-2219","DOI":"10.1016\/j.ymthe.2020.06.026"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kita S, Maeda N, Shimomura I. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Invest, 2019; 129: 4041-4049","DOI":"10.1172\/JCI129193"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fukuda S, Kita S, Miyashita K, Iioka M, Murai J, Nakamura T, Nishizawa H, Fujishima Y, Morinaga J, Oike Y, Maeda N, Shimomura I. Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum. J Clin Endocrinol Metab, 2021; 106: 1333-1344","DOI":"10.1210\/clinem\/dgab066"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) De Wever O, Derycke L, Hendrix A, De Meerleer G, Godeau F, Depypere H, Bracke M. Soluble cadherins as cancer biomarkers. Clin Exp Metastasis, 2007; 24: 685-697","DOI":"10.1007\/s10585-007-9104-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Hu QP, Kuang JY, Yang QK, Bian XW, Yu SC. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer. Int J Cancer, 2016; 138: 2804-2812","DOI":"10.1002\/ijc.29982"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Tang MKS, Yue PYK, Ip PP, Huang RL, Lai HC, Cheung ANY, Tse KY, Ngan HYS, Wong AST. Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. Nat Commun, 2018; 9: 2270","DOI":"10.1038\/s41467-018-04695-7"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Pfaff D, Schoenenberger AW, Dasen B, Erne P, Resink TJ, Philippova M. Plasma T-cadherin negatively associates with coronary lesion severity and acute coronary syndrome. Eur Heart J Acute Cardiovasc Care, 2015; 4: 410-418","DOI":"10.1177\/2048872614557229"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Schoenenberger AW, Pfaff D, Dasen B, Frismantiene A, Erne P, Resink TJ, Philippova M. Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease. PLoS One, 2015; 10: e0131140","DOI":"10.1371\/journal.pone.0131140"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) G\u00d6ddeke S, Knebel B, Fahlbusch P, H\u00d6rbelt T, Poschmann G, van de Velde F, Benninghoff T, Al-Hasani H, Jacob S, Van Nieuwenhove Y, Lapauw B, Lehr S, Ouwens DM, Kotzka J. CDH13 abundance interferes with adipocyte differentiation and is a novel biomarker for adipose tissue health. Int J Obes (Lond), 2018; 42: 1039-1050","DOI":"10.1038\/s41366-018-0022-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Baltr\u016bnien\u0117 V, Rink\u016bnait\u0117 I, Bogomolovas J, Bironait\u0117 D, Ka\u017eukauskien\u0117 I, \u0160imoli\u016bnas E, Ru\u010dnskas K, Puronait\u0117 R, Bukelskien\u0117 V, Grabauskien\u0117 AV. The Role of Cardiac T-Cadherin in the Indicating Heart Failure Severity of Patients with Non-Ischemic Dilated Cardiomyopathy. Medicina (Kaunas). 2020; 56: 27","DOI":"10.3390\/medicina56010027"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/12\/29_63305\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:49:19Z","timestamp":1715316559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/12\/29_63305\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63305","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"63305"}}